Global High-Priority Regulatory Events — March 25, 2026

25-03-2026

Chefs' Warehouse, Inc. (CHEF) DEF 14A proxy statement dated March 25, 2026, for the virtual annual meeting on May 8, 2026, seeks stockholder approval for the election of nine director nominees, ratification of the independent registered public accounting firm, and an advisory vote on executive compensation. Governance highlights include 78% board independence, 100% committee independence, 33% female and underrepresented group board diversity, stock ownership guidelines, clawback policy, and anti-hedging measures, with no noted governance shortcomings. The company reports stockholder outreach covering 40% of voting shares and strategies focused on market expansion and ESG initiatives, including fleet efficiency improvements.

• ·Annual Meeting: 10:00 a.m. EDT, Friday, May 08, 2026, virtual at www.virtualshareholdermeeting.com/chef26
• ·Voting matters: Proposal 1 (Election of Directors), Proposal 2 (Ratification of Auditors), Proposal 3 (Advisory Vote on Executive Compensation)
• ·Executive compensation tied to adjusted EBITDA (AEBITDA), ROIC, and share price goals
• ·Stockholder communications: ir@chefswarehouse.com or investors.chefswarehouse.com/corporate-governance/contact-the-board

25-03-2026

Merck announced a definitive agreement to acquire Terns Pharmaceuticals for $53.00 per share in cash, valuing the equity at approximately $6.7B ($5.7B net of cash), a 31% premium to the 60-day VWAP and 42% to the 90-day VWAP as of March 24, 2026. The deal expands Merck's hematology pipeline with TERN-701, an investigational oral allosteric BCR::ABL1 TKI in Phase 1/2 for CML, expected to close in Q2 2026 subject to antitrust approval and tender offer conditions, resulting in a $5.8B charge ($2.35/share) to Merck's Q2 and FY2026 results. While promising early clinical data shows encouraging responses and low adverse events, the transaction carries risks including regulatory delays and shareholder litigation.

• ·Dose escalation of CARDINAL trial completed January 2025 with no dose-limiting toxicities up to 500mg QD.
• ·Dose expansion initiated April 2025 with 320mg or 500mg QD cohorts (up to 40 patients each).
• ·Additional CARDINAL cohort added January 2026 for BCR::ABL1 resistance mutations (e.g., T315I) in ~20 patients.
• ·FDA granted Orphan Drug Designation for TERN-701 in CML in March 2024.
• ·Merck investor call held March 25, 2026 at 8 a.m. EDT.
• ·Transaction via tender offer; merger agreement to be filed with SEC.

25-03-2026

Cipher Digital Inc., a subsidiary of Cipher Mining Inc., entered into a senior secured revolving credit agreement dated March 23, 2026, with a lender syndicate led by Morgan Stanley Senior Funding, Inc. as Administrative Agent and Collateral Agent, and joint arrangers including Banco Santander, Goldman Sachs Lending Partners LLC, JPMorgan Chase Bank, N.A., Sumitomo Mitsui Banking Corporation, and Wells Fargo Securities, LLC. Proceeds are for working capital and general corporate purposes, with interest margins starting at Term SOFR +1.750% / ABR +0.750% (adjustable down to +1.250% / +0.250% based on Consolidated Total Debt to Market Capitalization Ratio <0.30x) and a 0.50% commitment fee; no facility size or drawdowns specified.

• ·Pricing grid based on Consolidated Total Debt to Market Capitalization Ratio: Level 1 (<0.30:1) 1.250%/0.250%; Level 2 (0.30-0.60:1) 1.500%/0.500%; Level 3 (>0.60:1) 1.750%/0.750% for Term SOFR/ABR.
• ·Initial pricing effective until Compliance Certificate for fiscal quarter ending September 30, 2026.
• ·Alternate Base Rate defined as highest of 1.00%, Prime Rate, Federal Funds Effective Rate + 0.50%, or Adjusted Term SOFR (1-month) + 1.00%.

25-03-2026

Carvana Co.'s DEF 14A Proxy Statement for the 2026 Annual Meeting on May 5, 2026, seeks stockholder approval for electing Michael Maroone and Neha Parikh as Class III directors until 2029, an advisory say-on-pay vote for named executive officers, the new 2026 Omnibus Incentive Plan, a five-for-one forward stock split of Class A and Class B common stock with proportionate authorized share increases, ratification of Grant Thornton LLP as auditors for 2026, and a stockholder proposal. As of the March 10, 2026 record date, 142,993,769 Class A shares and 76,109,471 Class B shares were outstanding, with Garcia Parties entitled to 10 votes per Class B share. No financial performance metrics or period comparisons are detailed in the filing.

• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/CVNA2026 at 2:30 p.m. PDT on May 5, 2026
• ·Record date: March 10, 2026
• ·Proxy materials notice mailed on or about March 25, 2026; paper copies requested by April 21, 2026
• ·Garcia Parties entitled to 10 votes per Class B share while maintaining at least 25% beneficial ownership assuming full Class A Unit exchange

25-03-2026

Sterlite Technologies Limited (STL) launched India’s first Hollow Core Fibre (HCF) cable for Data Centre networks, enabling signals to travel ~46% faster through an air-filled core, reducing latency and signal loss compared to traditional solid glass core fibres. The hybrid cable integrates HCF for ultra-low latency, G.654.E Fibre for low-loss long-haul, and G.657.A1 NOVA for versatility. This R&D breakthrough, highlighted by CTO Dr Badri Gomatam, reinforces STL’s leadership with over 780 patents in AI-ready optical connectivity.

• ·STL delivers solutions in more than 100 countries with manufacturing in North America, Europe, and Asia.
• ·Filing date: March 25, 2026; Scrip ID: STLTECH (NSE), Scrip Code: 532374 (BSE).

25-03-2026

Gandhar Oil Refinery (India) Limited has closed its Trading Window for Designated Persons, Connected Persons, and their immediate relatives from April 1, 2026, until 48 hours after the declaration of Audited Financial Results for the quarter and year ended March 31, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The Board Meeting date for approving these results will be announced separately. No financial data or performance metrics are disclosed in this intimation.

• ·BSE Scrip Code: 544029
• ·NSE Symbol: GANDHAR
• ·Membership No.: ACS 29802
• ·Trading Window closure starts: Wednesday, April 01, 2026

25-03-2026

IHP Finvest Limited, promoter group and holding company of The Indian Hume Pipe Company Limited, has fully released the pledge on 1,16,94,995 equity shares (22.20% of total share capital) previously held in favor of SBICAP Trustee Company Limited to secure working capital facilities worth ₹187.5 Cr advanced to the company. Post-release on March 24, 2026, IHP Finvest holds no outstanding pledged shares, with its total shareholding remaining at 3,56,04,145 shares (67.58%). This development signals improved financial position and reduced encumbrance risk for the promoter.

• ·Pledge released on March 24, 2026; disclosure filed March 25, 2026.
• ·Pledge was for consortium of banks led by State Bank of India.

25-03-2026

Acquirers Mr. Arvind Karsandas Bhanushali, Mrs. Deepali Arvind Bhanushali, Mr. Jay Arvind Bhanushali, Mr. Nikunj Velji Mange, and Mr. Raj Arvind Bhanushali, along with PAC Mrs. Shraddha Nikunj Mange, propose an open offer for 26,76,180 equity shares (26% of Aspira Pathlab & Diagnostics Limited's fully paid-up equity share capital and voting capital) at ₹55 per share. Aftertrade Broking Private Limited, as Manager to the Open Offer, has fixed the Identified Date as March 27, 2026, to determine eligible shareholders for the Letter of Offer. No financial performance metrics or period-over-period changes are disclosed in this filing.

• ·Public Announcement dated 26/09/2025
• ·Detailed Public Statement published on 06/10/2025
• ·Draft Letter of Offer dated 13/10/2025
• ·Aftertrade Broking Private Limited SEBI Registration Number: INM000013110
• ·Vanesh Panchal DIN: 06944544

25-03-2026

Amneal Pharmaceuticals, Inc. (AMRX) issued its 2026 Proxy Statement for the annual stockholder meeting on May 6, 2026, seeking votes to elect 10 director nominees, approve named executive officer compensation on an advisory basis, and ratify Ernst & Young LLP as independent auditors for fiscal 2026. The accompanying letter from Co-CEOs Chintu Patel and Chirag Patel highlights 2025 achievements, including 8% YoY revenue growth driven by strong Specialty (+double-digit) and Affordable Medicines segments, CREXONT® uptake reaching approximately 22,000 patients, multiple product launches and approvals, and debt refinancing to extend maturities to 2032; no declines or flat performances were noted. The company underscores its diversified portfolio of over 290 marketed products, 110+ pipeline programs, and strategy across Specialty, Affordable Medicines (including biosimilars), and AvKARE.

• ·Record date: March 12, 2026
• ·Annual meeting: May 6, 2026 at 9:00 a.m. EDT, virtual at www.virtualshareholdermeeting.com/AMRX2026
• ·Fiscal year end: December 31
• ·Debt maturities extended from 2028 to 2032 via refinancing

25-03-2026

Progress Software Corp /MA filed its 2026 DEF 14A Proxy Statement ahead of the annual stockholder meeting on May 7, 2026, seeking approval for the election of directors, an advisory vote on named executive officer compensation, an increase in authorized shares under the 2008 Stock Option and Incentive Plan, an increase in shares for the 1991 Employee Stock Purchase Plan, and ratification of the independent auditor. The document provides a business overview emphasizing the company's mission to power AI experiences through products in digital experiences, application and data platforms, and infrastructure management, with a Total Growth Strategy focused on innovation, customer retention for recurring revenue, and M&A-driven growth. No financial performance metrics or period-over-period comparisons are detailed in the provided content.

• ·Annual meeting date: May 7, 2026
• ·Fiscal year end: November 30
• ·Proposals include increases in authorized shares for 2008 Stock Option and Incentive Plan and 1991 Employee Stock Purchase Plan
• ·XBRL tags reference PEO and non-PEO compensation metrics (e.g., grant date fair values, changes in fair value) for fiscal years 2021-2025, but no numerical values provided

25-03-2026

Koura Fine Diamond Jewelry Limited has intimated BSE Limited that the trading window for dealing in its equity shares will remain closed from April 1, 2026, for all designated persons and their immediate relatives, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window shall reopen 48 hours after the announcement of financial results for the half year and year ended March 31, 2026, at the forthcoming Board Meeting. The Board Meeting date will be intimated separately.

• ·CIN: L36999GJ2022PLC130379
• ·Script Code: 543346
• ·Registered Office: G/F-02, Sigma Icon-2, Opposite Medilink Hospital, 132ft Ring Road, Shyamal Square, Satellite, Jodhpur Char Rasta, Ahmedabad - 380015

25-03-2026

The 22nd Committee of Creditors (COC) meeting for Bloom Dekor Limited, currently in Corporate Insolvency Resolution Process (CIRP), was held on March 19, 2026, where a resolution plan from Dr. Sunil Gupta was received by the deadline of March 16, 2026, and presented to members. The COC approved a ₹60 Lakh EMD refund to Mishtann Foods Limited following its withdrawal, authorized due diligence on the resolution applicant under Section 29A, and appointed B. T. Vora & Co. as internal auditors for ₹60,000 plus GST; however, an application for 120-day CIRP extension and litigation period exclusion was filed due to ongoing delays. No financial recovery or positive operational metrics were reported amid the prolonged insolvency process.

• ·CIRP extension application filed on March 16, 2026, seeking exclusion of litigation period until January 13, 2026, and additional 120 days.
• ·CS Tushar Dineshbhai Donda resigned w.e.f. November 19, 2024.
• ·Company CIN: L20210GJ1992PLC017341.

25-03-2026

SOBR Safe, Inc. received a Nasdaq deficiency letter on March 19, 2026, notifying failure to satisfy the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2) for 30 consecutive business days. Prior reverse stock splits (1-for-110 on October 2, 2024, and 1-for-10 on April 4, 2025, cumulative 1-for-1100) render the company ineligible for the standard 180-day compliance period. The company intends to appeal to a hearings panel with a compliance plan, staying delisting pending hearing, though success is not assured.

• ·Company's common stock continues to trade on Nasdaq under ticker 'SOBR' with no immediate delisting effect.
• ·Notification does not impact business operations or SEC reporting requirements.
• ·Cumulative reverse stock split ratio over last two years: 1-for-1100, exceeding 1-for-250 threshold for standard compliance period.

25-03-2026

The 7th Meeting of the Committee of Creditors (CoC) for Unitech International Ltd was held on March 24, 2026, via video conferencing, where key agenda items on appointing legal counsel, PCS firm for compliances, ratifying RP expenses under Regulation 34, fees for Accountant Mr. Rohit Sharma, and statutory auditor fees were all deferred to the next meeting due to paucity of time. However, the resolution to approve the Request for Resolution Plan (RFRP) and Evaluation Matrix for the Corporate Debtor to Prospective Resolution Applicants (PRAs) was passed unanimously with 100% voting rights. This disclosure was filed on March 25, 2026, in compliance with SEBI LODR Regulation 30.

• ·Scrip Code: 531867, Name: UNITINT
• ·RP IBBI Registration: IBBI/IPA-002/IP-N00828/2019-2020/12629, AFA Valid Till: June 30, 2026

25-03-2026

Rentokil Initial PLC's FY2025 revenue increased 4% YoY to $6,908M from $6,617M, supported by organic growth and bolt-on M&A activity. However, operating profit declined 9% to $584M due to higher operating expenses of $6,250M (up 6% YoY), and profit from continuing operations fell 16% to $290M. Total profit rose 20% YoY to $470M, boosted by $180M from discontinued operations (vs $46M prior), with net assets up 4% to $5,494M and cash at $2,319M.

• ·Basic EPS from continuing operations declined to 11.49 cents (FY2024: 13.72 cents).
• ·Basic EPS from total operations: 18.62 cents (FY2024: 15.54 cents).
• ·Dividends paid to equity shareholders: $304M in FY2025 (FY2024: $292M).
• ·Total borrowings increased to $5,567M at Dec 31 2025 from $4,587M at Dec 31 2024.
• ·Audited by PricewaterhouseCoopers LLP (PCAOB ID 876).

25-03-2026

CECO Environmental Corp and Thermon Group Holdings, Inc. executives discussed their pending merger at the 38th Annual ROTH Conference, emphasizing commercial synergies in controls (e.g., Thermon's Genesis platform), cross-selling heat trace and immersion heaters on CECO's $6.5B sales pipeline, and operational expansion in Asia. Thermon highlighted its 3D strategy success, reducing oil/gas exposure from 65% to 28-30% of revenues with 9% adjusted topline growth since 2017 and shift to 83% OpEx recurring revenues. The combined entity is projected to achieve double-digit growth and 20%+ EBITDA margins under Rule of 30/40.

• ·Thermon backlog and engineering at record high.
• ·Customers' CapEx spending up 26% this year, expected to continue.
• ·Merger discussions evolved from mutual admiration and non-competitive overlap into full acquisition announcement a few weeks prior to March 24, 2026.

25-03-2026

Sandisk Technologies, Inc., a wholly-owned subsidiary of Sandisk Corporation, entered into a Private Placement Subscription Agreement with Nanya Technology Corporation on March 25, 2026, to purchase approximately 139 million shares of Nanya common stock for $1.0B, representing 3.9% of Nanya’s outstanding common stock on a fully diluted basis at a 15% discount to the 30-day average trading price. Concurrently, the companies entered a multi-year strategic supply arrangement for Nanya to supply DRAM products to support Sandisk's long-term sourcing strategy. The transaction shares are subject to a statutory 3-year lock-up period under Taiwanese law.

• ·Transaction conducted pursuant to Article 43-6 of the Taiwan Securities and Exchange Act, subject to post-closing filings with Taiwan Stock Exchange and other regulators.
• ·Shares subject to statutory 3-year lock-up from delivery, with limited transfer exceptions under Taiwanese law.

25-03-2026

Spectral AI's R&D revenue declined 33.6% YoY to $19.65M in 2025 from $29.58M in 2024, resulting in gross profit falling to $8.93M (down 32.7% YoY) despite a slight gross margin improvement to 45.4% from 44.9%. Operating loss widened to $8.60M from $6.58M, but net loss narrowed to $7.57M from $15.16M, driven by favorable changes in warrant liabilities and other income. Adjusted EBITDA deteriorated to $(7.42M) from $(5.54M).

• ·Dependence on BARDA contract as largest single source of revenue, not guaranteed to be fully awarded or extended.
• ·2024 financials reflect $157K adjustment to income tax provision.
• ·Favorable $7.88M YoY change in fair value of warrant liabilities contributed to net loss improvement.

25-03-2026

NOVAGOLD RESOURCES INC has issued its 2026 Proxy Statement for the Annual General Meeting on May 14, 2026 (record date March 18, 2026), seeking approval for director elections (10 nominees, 7 independent), auditor appointment (PricewaterhouseCoopers LLP), amendments to stock plans, and advisory votes on executive compensation and frequency. The company highlights strong governance practices including 100% independent key committees, separate Chairman/CEO roles, annual director elections, and stock ownership guidelines (e.g., directors $128,400 or 3x retainer). However, it notes proactive engagement with shareholders who voted against 2025 executive compensation (holders of ~34% of shares), following outreach to 89.92% of shares.

• ·Proxy voting deadline: May 12, 2026, 4:00 p.m. ET
• ·Virtual meeting webcast: www.virtualshareholdermeeting.com/NG2026
• ·CEO stock ownership guideline: 5x annual base pay within 5 years
• ·CFO/COO stock ownership guideline: 2x annual base pay within 5 years
• ·Prohibitions: hedging/pledging of stock by directors/employees

25-03-2026

Social Commerce Partners Corp (SCPQ), a SPAC, reported total assets of $101.1M as of December 31, 2025, including $100.1M in marketable securities held in the Trust Account from its IPO proceeds of $98.0M net plus $3.5M private placement. The company incurred a net loss of $0.58M for the period from inception (August 11, 2025) through year-end, driven by $0.52M compensation expense and $0.13M G&A costs, offset slightly by $0.06M interest income, resulting in a shareholders' deficit of $2.6M. Cash position stood at $1.0M outside the Trust, with no prior periods for comparison.

• ·Loss from operations: $0.64M
• ·Interest income: $59,591
• ·Deferred underwriting fee: $3.5M
• ·Net cash used in operating activities: $73,500
• ·Basic and diluted net loss per share: $0.15 (Class A and Class B)
• ·Net cash provided by financing activities: $101.1M

25-03-2026

UiPath reported total revenue of $1.61B for FY2026 ended January 31, 2026, up 13% YoY from $1.43B, driven by 19% growth in subscription services to $954M, while licenses grew modestly 3% to $606M and professional services rose 23% to $50M. The company achieved profitability with operating income of $57M (4% margin) versus a $163M loss (-11% margin) and net income of $282M versus a $74M loss, aided by lower operating expenses (down to 79% of revenue from 94%) including reduced stock-based compensation and restructuring costs. However, cost of professional services increased to 7% of revenue from 5%, and other expense worsened.

• ·Amortization of acquired intangible assets totaled $8.2M in FY2026, up from $6.7M.
• ·Stock-based compensation expense decreased to $291M from $358M YoY.
• ·Restructuring expenses fell sharply to $4.4M from $25M.
• ·Benefit from income taxes was $182M in FY2026.

25-03-2026

TLGY Acquisition Corp. issued this Rule 425 filing on March 25, 2026, disclosing a March 24, 2026 X.com post by Edward Chen, Chairman of SC Assets, regarding the proposed business combination with StableCoinX Inc., originally announced via agreement on July 21, 2025. The transaction aims to make TLGY and SC Assets subsidiaries of StablecoinX, enabling StablecoinX to become publicly traded, with the Registration Statement declared effective on February 17, 2026. The filing emphasizes forward-looking statements and substantial risks, including potential delays, high redemptions by TLGY shareholders, ENA price volatility, regulatory hurdles, and failure to realize anticipated benefits.

• ·Business Combination Agreement entered on July 21, 2025
• ·Registration Statement on Form S-4 declared effective on February 17, 2026
• ·TLGY's business combination deadline referenced as a closing condition risk

25-03-2026

Vector 21 Holdings, Inc. reported no revenue for FY ended June 30, 2025, with a reduced net loss of $23,966 (down 40% YoY from $40,273) due to lower G&A expenses ($24,326 vs. $38,833). However, cash and cash equivalents depleted to $0 from $52, total liabilities rose 18% to $155,965 driven by higher accounts payable and related-party loans, and shareholders' deficit worsened to $(155,965). The company qualifies as an inactive registrant with minimal activity.

• ·Accounts payable and accruals increased to $72,106 from $51,832.
• ·Loan payable-related party rose to $32,399 from $28,399.
• ·Promissory note-related party slightly declined to $51,460 from $51,820.
• ·No investing activities in either year.
• ·Net cash from financing activities dropped sharply to $4,000 from $22,080.

25-03-2026

CoJax Oil & Gas Corp's FY 2025 net loss narrowed to $1.11M from $1.61M in FY 2024 (-31.1% YoY), supported by a 56.4% drop in impairment expense to $402K and 15.7% lower G&A expenses at $776K, alongside positive operating cash flow of $41K versus a $19K outflow. However, revenues were nearly flat at $964K (-0.8% YoY), lease operating expenses increased 17.5% to $418K, total assets declined to $9.58M from $10.51M, and stockholders' equity fell to $7.85M from $8.62M.

• ·Proved properties at cost: $8.1M (2025) vs $8.9M (2024)
• ·Accumulated depletion: ($900K) (2025) vs ($767K) (2024)
• ·Accounts receivable net: $110K (2025) vs $147K (2024)
• ·Common stock issued for accrued salaries: $340K (2025)

25-03-2026

Greenpanel Industries Limited announced the closure of the trading window for designated persons and their immediate relatives from April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and year ending March 31, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The board meeting date for approving these results will be communicated separately.

• ·Scrip Code: 542857
• ·Symbol: GREENPANEL

25-03-2026

Inflection Point Acquisition Corp. VI, a blank check SPAC, filed Amendment No. 2 to its S-1 registration statement on March 24, 2026, for a proposed $220M IPO of 22M units priced at $10 each, comprising one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50. The sponsor, Inflection Point Holdings VI LLC, holds 8,433,333 Class B ordinary shares and commits to 5M private placement warrants at $1 each, alongside 2.4M from Cantor Fitzgerald & Co., totaling $7.4M; IPF intends a $25M PIPE. The offering includes a 45-day underwriter option for 3.3M additional units and a 24-month window to complete an initial business combination, with public share redemptions limited to 15% aggregate per shareholder group.

• ·Warrants exercisable 30 days post-initial business combination, expire 5 years after or upon redemption/liquidation.
• ·Trust account funds releasable only post-combination except $500K annual working capital (plus rollover) and taxes.
• ·Sponsor Class B shares convertible to Class A on 1:1 basis pre-combination.
• ·Principal executive offices: 1680 Michigan Avenue Suite 700 #1031, Miami Beach, FL 33139.
• ·Nasdaq listing intended: IPFXU for units.

25-03-2026

Range Capital Acquisition Corp II (RNGTW), a SPAC, reported total assets of $233.4M as of December 31, 2025, with $232.1M held in the Trust Account from 23M Class A ordinary shares at $10.09 redemption value. For the period from inception (May 22, 2025) through year-end, the company posted net income of $1.8M driven by $2.1M interest income, but incurred an operating loss of $0.3M from G&A expenses, resulting in a shareholders' deficit of $6.9M.

• ·Cash balance: $1.1M; Prepaid expenses: $85K; Long-term prepaid insurance: $53K
• ·Accounts payable and accrued expenses: $11K; Accrued offering costs: $75K
• ·Basic and diluted EPS for Class A and B shares: $0.12
• ·Possible working capital loans up to $1.5M convertible into units at $10.00 per unit

25-03-2026

Pasqal Holding SAS, the target in the proposed business combination with Bleichroeder Acquisition Corp. II, plans a Nasdaq listing in 2026 followed by a secondary Euronext listing, highlighting its neutral-atom quantum computers with ~200 qubits, a 2024 1,000-qubit demonstration, and manufacturing lead times reduced to 9-12 months from over two years. The company signed an MOU with Seoul Metropolitan Government for a quantum R&D center involving $52.84M investment and 51 new jobs, while expanding partnerships with LG Electronics, BMW, EDF, Thales, and Crédit Agricole CIB. Pasqal aims to scale to 10,000-qubit systems using Photonic Integrated Circuits and positions itself as a leader with a workforce of over 275 employees, including ~70 PhDs.

• ·Pasqal founded in 2019 at Institut d’Optique, France; first commercialized 200-qubit quantum computer.
• ·Quantum computers delivered to GENCI (France, 2024), Aramco (Saudi Arabia, 2025), and installed in Italy, Canada, Germany.
• ·Three of eight EuroHPC JU commissioned quantum computers are Pasqal models.
• ·Manufacturing facility expanded with nine QPU bays; additional production site in Canada.
• ·Operates at room temperature (~20°C) using laser-based neutral-atom control, no cryogenic cooling required.

25-03-2026

Range Capital Acquisition Corp. reported net income of $4.0M for the year ended December 31, 2025, a turnaround from a $39K loss in the period from inception (July 24, 2024) through December 31, 2024, primarily driven by $4.8M in interest earned on the Trust Account. However, operating costs increased significantly to $803K from $147K over the comparable periods, resulting in a larger operating loss. The Trust Account balance grew to $120.5M as of December 31, 2025, from $100.6M a year earlier, with redemption value rising to $10.48 per share.

• ·Up to $1.5M in non-interest bearing loans from initial shareholders, officers, or directors may be convertible into working capital units at $10.00 per unit.
• ·Shareholders’ equity decreased to $211K as of Dec 31, 2025 from $847K as of Dec 31, 2024.
• ·Over-allotment option liability settled to $0 from $148K.

25-03-2026

Pure Storage, Inc. reported total revenue of $3.66B for FY2026, up 16% YoY from $3.17B in FY2025, driven by 16% growth in product revenue to $1.97B and 15% in subscription services revenue to $1.69B; subscription ARR also grew 16% YoY to $1.92B. However, operating expenses increased notably with R&D up 20% to $725M, sales and marketing up 17% to $1.08B, and total cost of revenue up 14% to $1.08B, while gross margins remained flat at 70%. Net cash from operating activities improved to $880M, though financing cash use deepened.

• ·Product gross margin improved slightly to 67% from 66% YoY.
• ·Subscription services gross margin flat at 74% YoY.
• ·G&A expenses increased 10% YoY to $229M.
• ·Net cash used in investing activities improved to $(108M) from $(218M).
• ·Net cash used in financing activities increased to $(645M) from $(510M).

25-03-2026

Integra Resources Corp. (ITRG) filed its Form 40-F Annual Report for the fiscal year ended December 31, 2025, incorporating the Annual Information Form, audited financial statements for 2025 and 2024 under IFRS, and MD&A. Management confirmed effective disclosure controls, internal controls over financial reporting, and no material changes or restatements. At the Florida Canyon Mine, MSHA issued 100 Section 104 S&S citations with $1,242 in proposed assessments but no fatalities, orders, or patterns of violations.

• ·Exchange rate on December 31, 2025: Cdn.$1.00 = U.S.$0.7296
• ·No off-balance sheet arrangements
• ·No waivers of Code of Business Conduct and Ethics during FY 2025
• ·No Regulation BTR blackout notices during FY 2025
• ·No recovery of erroneously awarded compensation required as of December 31, 2025

25-03-2026

Concord Acquisition Corp II reported net income of $556,003 for FY 2025, a turnaround from a $766,076 loss in FY 2024, driven by a 41% reduction in operating costs to $1.265M and positive changes in fair value of financial instruments. However, cash in Trust Account plummeted 99.6% to $99,373 amid $23.8M withdrawals related to redemptions that reduced redeemable shares from 2.2M to 8,550, leaving total assets at just $354k versus $24.7M prior year, with cash declining 63% to $197k. Stockholders’ deficit improved slightly to $(8.75M) from $(8.97M), but liquidity remains critically low.

• ·Excise tax payable increased to $2.86M at Dec 31, 2025 from $2.46M.
• ·Capital Contribution Note fair value decreased to $1.96M from $3.54M.
• ·Warrant liability decreased to $604K from $737K.
• ·Net cash used in operating activities improved to $929K used from $1.55M used.
• ·Federal income tax paid $20K in 2025 vs $671K in 2024.

25-03-2026

Securetech Innovations, Inc. (SCTH) reported audited FY2025 revenue of $7.7 million, substantially all from AI UltraProd, acquired on June 23, 2025, which now serves as its primary operating business. The company outlined a 2026 roadmap including NASDAQ uplisting in Q2, expansions into U.S. and Indonesian markets, an investor awareness program starting late February, and M&A targeting $5-10M revenue companies. However, it highlighted extensive risks such as material weaknesses in internal controls, dependence on key personnel like J. Scott Sitra, potential market non-acceptance, and challenges with inventory management and competition.

• ·Piranha Blockchain is an early-stage enterprise focused on digital-asset infrastructure and cybersecurity.
• ·Terra Nova Technologies (Top Kontrol) is a legacy product line undergoing restructuring for planned spin-off to OTCQB.
• ·Product revenue streams include one-time cybersecurity sales, subscription services, cryptocurrency ventures, and transaction fees.

25-03-2026

Aldel Financial II Inc., a blank check company (SPAC), filed its 10-K for the year ended December 31, 2025, reporting no principal operations and a trust account balance of $243.0M (approximately $10.57 per public share), up from $231.2M initially funded post-IPO due to interest income. The company raised $230.0M gross proceeds from its October 23, 2024 IPO of 23.0M units at $10.00 each (including over-allotment) and $7.1M from private placements, while holding $0.5M cash outside the trust. It continues seeking a business combination in financial services within a 24-month window, with no redemptions or withdrawals from trust for taxes to date.

• ·IPO registration statement effective Oct 21, 2024; Public Warrants exercisable at $11.50/share after BC or 12 months post-IPO.
• ·24-month period to complete initial Business Combination (from Oct 23, 2024).
• ·No interest withdrawn from trust for taxes as of Dec 31, 2025.
• ·Sponsor transferred 690,000 founder shares to management and board on Aug 13, 2024.

25-03-2026

Morgan Stanley Capital I Trust 2019-H6 filed its 10-K annual report on March 25, 2026, containing Regulation AB servicing criteria compliance assertions from servicers Midland, K-Star, PBLS, an unnamed Company, and CoreLogic. Most criteria are affirmed as performed directly or by responsible vendors, while others are designated N/A, not performed by the servicer, or inapplicable depending on the entity. No material non-compliance, deficiencies, or exceptions are reported across the board.

• ·Multiple criteria marked N/A (e.g., back-up servicer requirements, investor reporting specifics) or 'NOT performed' by certain servicers where inapplicable to their role.
• ·Footnotes referenced (e.g., 1,2,3,4,i,Xi) for certain assertions, but details truncated.

25-03-2026

HNO International reported no revenue for the three months ended January 31, 2026 or 2025, resulting in a net loss of $182,069, a 96.7% improvement from the prior year's $5.46M loss, driven by sharply lower operating expenses ($188K vs. $5.45M). Cash balance increased to $81K from $10K QoQ, supported by $198K in financing inflows, though total assets declined 20% QoQ to $1.39M amid a stockholders' deficit widening slightly to $1.70M. Operating cash burn improved to $126K from $168K YoY but remains negative with ongoing reliance on related party advances and stock sales.

• ·Convertible note payable converted to 193,164 common shares under Regulation A.
• ·Related party advances increased by $130K during Q1 2026.
• ·Property and equipment, net declined to $1.26M from $1.32M QoQ due to $65K depreciation.
• ·Unregistered sales: 500,000 shares to Raymond Renfrow (Reg D, Nov 2025), 33,334 shares to Kevin Bens (Reg A, Dec 2025), 333,334 shares to Tri-Bridge Ventures, LLC (Reg A, Jan 2026).

25-03-2026

Braze, Inc. (BRZE) reported FY2026 revenue of $738.2M, up 24.4% YoY from $593.4M in FY2025, with gross profit rising 20.8% to $495.7M. However, cost of revenue increased 32.4% to $242.5M, causing gross margin to contract slightly to 67.1% from 69.1%, while operating loss widened to $144.8M from $122.2M and net loss grew to $130.8M from $104.0M amid elevated operating expenses (up to 87% of revenue from 90%). Positively, net cash provided by operating activities more than doubled to $71.4M from $36.7M, and non-GAAP free cash flow improved to $58.1M from $19.6M.

• ·Sales and marketing expenses reached $327.0M in FY2026, up from $247.1M in FY2024.
• ·Research and development expenses increased to $167.1M in FY2026 from $119.9M in FY2024.
• ·Total operating expenses were 87% of revenue in FY2026, improved from 99% in FY2024.
• ·Net cash used in investing activities was $50.9M in FY2026, up from $20.0M in FY2024.

25-03-2026

AAR Corp's Q3 FY26 sales surged 25% YoY to $845.1M, with products up 30% to $539.5M and services up 17% to $305.6M, driving net income of $68.0M versus a $8.9M loss prior year; nine-month sales grew 18% to $2.38B with net income $137.0M versus $21.5M loss. However, Q3 operating income fell 7% YoY to $65.8M amid SG&A expenses rising 47% to $89.8M, and nine-month cash from operations was modest at $43.4M after $222M acquisition outflow and $24.6M capex. Balance sheet expanded with total assets at $3.33B (up 17% QoQ) and equity $1.64B (up 36%), but inventories rose 19% to $958.2M and cash declined to $78.5M.

• ·Equity offering proceeds funded growth, with common stock issued increasing to 48.8M shares from 45.3M.
• ·Net cash used in investing activities $251.8M for nine months, primarily acquisitions.
• ·Purchase price for recent acquisition $78.0M net of cash acquired, with net assets $113.7M.

25-03-2026

byNordic Acquisition Corp reported a widened net loss of $731,544 for the year ended December 31, 2025, compared to $206,537 in 2024, primarily due to a 74% decline in interest income to $398,336 amid a 53% drop in Trust Account balance to $5.5M following redemptions of shares. While operating costs improved 27% YoY to $1.06M and cash balance rose 24% to $338K, total liabilities increased 11% to $14.7M driven by higher related-party promissory notes ($7.7M, up 23%), and stockholders' deficit deepened to $14.4M.

• ·Deferred underwriters’ discount remained at $6.0M as of Dec 31, 2025.
• ·Excise tax payable decreased to $70,197 from $295,573 YoY.
• ·Net cash used in operating activities improved to $1.1M from $3.0M YoY.

25-03-2026

Brand Engagement Network Inc. announced that Bernard Puckett notified the Board he will step down as Chairman and resign as a director effective March 31, 2026, after serving as Interim Chairman since August 2025 and Board member since April 2023; his departure is not due to any disagreements. The Board appointed independent director Jon Leibowitz as the new Chairman effective April 1, 2026. Mr. Leibowitz brings extensive experience from roles at the Federal Trade Commission, Davis Polk & Wardwell LLP, and as Chairman of the National Consumers League.

• ·Puckett served as Chair of the Audit Committee and member of Compensation Committee and Nominating and Corporate Governance Committee.
• ·Leibowitz currently serves as Chair of the Nominating and Corporate Governance Committee and member of the Audit Committee.
• ·Resignation letter from Puckett dated March 20, 2026, attached as Exhibit 17.1.

25-03-2026

Stepan Co's DEF 14A proxy statement outlines its 2025 board and committee activities, with the Board holding 5 meetings and all directors attending more than 75% of Board and committee meetings. Standing committees (Audit, Compliance, Human Capital and Compensation, Nominating and Corporate Governance) held 3-4 meetings each, comprised entirely of independent directors Ms. Burgess, Mr. Dearth, Mr. Delgado, Ms. Lewis, Mr. Painter, and Ms. Reed, with Ms. Burgess as audit committee financial expert. F. Quinn Stepan Jr. and Luis E. Rojo are not independent due to family ties and CEO role, respectively.

• ·All directors except retired Mr. Wehmer (virtual) attended the 2025 Annual Meeting in person; all current directors and nominees expected at 2026 Annual Meeting.
• ·Stockholder recommendations for director nominees must be submitted in writing to Secretary at 1101 Skokie Boulevard, Northbrook, Illinois 60062, per By-laws; deadline for 2027 Annual Meeting specified in proposals section.
• ·Compensation-related XBRL disclosures cover Principal Executive Officer (PEO) and Non-PEO Named Executive Officers (NEOs) for periods 2021-2025, including equity awards adjustments and fair value changes.

25-03-2026

The Chiba Kogyo Bank, Ltd. announced the repurchase of up to 1,500,000 Class II Preferred Shares for ¥6B, up to 301,000 2nd Series of Class VI Preferred Shares for ¥6.1B, and up to 4,723 2nd Series of Class VII Preferred Shares for ¥2.4B, as preparation for a joint share transfer with The Chiba Bank, Ltd. to establish Chiba Financial Group, Inc. effective April 1, 2027. Repurchases will occur via agreement with shareholders from July 1, 2026, to January 31, 2027, following the prior cancellation of 1st Series of Class VII Preferred Shares on April 1, 2026. The move aims to maintain a capital ratio of at least 8% post-transaction.

• ·Bank plans to secure capital ratio of at least 8% post-Share Transfer through Joint Holding Company support.
• ·Repurchase methods involve agreements with specific preferred shareholders, with notice or public announcement.
• ·Future Form F-4 filing planned with SEC for the Share Transfer.

25-03-2026

The Committee of Independent Directors (IDC) of Grameva Limited (formerly Bangalore Fort Farms Limited) recommends acceptance of the open offer by Acquirers Mrs. Maneesha Singh, Jagsakti Merchandise Private Limited, and Ros Advisory Private Limited for up to 12,47,844 equity shares (26% of total paid-up equity capital) at ₹30 per share, deeming it fair and reasonable as it exceeds the certified fair value of ₹26.21 and negotiated price of ₹28. However, the shares are infrequently traded with no trading on CSE for years and current BSE trading price above the offer price, advising shareholders to independently evaluate before tendering.

• ·No complaints received from shareholders regarding the open offer, valuation price, or method.
• ·Equity shares infrequently traded: BSE turnover <10% of total shares in preceding 12 months; no trading on CSE for many years.
• ·Key dates: Public Announcement Jan 31, 2026; Letter of Offer Mar 16, 2026; IDC recommendation Mar 24, 2026.
• ·No IDC member trading in target shares since PA; no relationships with acquirers.

25-03-2026

On March 18, 2026, Ingredion Incorporated's Board of Directors elected Jason Payant as Interim Chief Financial Officer effective April 1, 2026, succeeding James D. Gray, whose resignation as EVP and CFO was effective March 31, 2026. Mr. Payant, age 55, has served the company since 2012 in various senior finance roles, including Vice President, Finance, Global Texture & Healthful Solutions since November 2025. He will receive $25,000 monthly cash compensation in addition to his existing compensation and benefits during his interim tenure.

• ·Jason Payant previously served as Vice President, Finance, Food & Industrial Ingredients U.S./Canada from January 2024 to November 2025, Interim Vice President, Investor Relations from September 2021 to October 2022, and Vice President, Finance from October 2017 to January 2024.
• ·No arrangements or understandings with other persons for Mr. Payant's selection; no material transactions involving Mr. Payant or his family.
• ·James D. Gray's resignation reported on January 27, 2026.

25-03-2026

Coal India Limited has disclosed under Regulation 30 of SEBI LODR the filing of the Prospectus dated March 24, 2026, for the IPO of its wholly-owned subsidiary Central Mine Planning & Design Institute Limited (CMPDIL), comprising an Offer for Sale of up to 107,100,000 equity shares of face value ₹2 each. This follows the Red Herring Prospectus filed on March 12, 2026, and a prior disclosure on March 13, 2026. The prospectus was submitted to the Registrar of Companies, Jharkhand at Ranchi on March 25, 2026.

• ·ISIN: INE522F01014
• ·Scrip Code: 533278
• ·Prospectus filed with Registrar of Companies, Jharkhand at Ranchi

25-03-2026

HBT Financial, Inc. announced the appointment of Michael J. Morton to the Board of Directors of HBT Financial and Heartland Bank, effective April 1, 2026, with his initial term expiring at the 2026 Annual Meeting of Stockholders. Mr. Morton brings nearly 40 years of banking experience, including as Vice Chair of U.S. Commercial Banking at BMO (2020-2023) and Executive Vice President and Chief Credit Officer at MB Financial (2014-2019). As of December 31, 2025, HBT Financial reported total assets of $5.1B, total loans of $3.5B, and total deposits of $4.4B.

• ·HBT Financial operates 83 full-service branches in Illinois, eastern Iowa, and suburban St. Louis.
• ·Mr. Morton holds a BS from Illinois State University and an MBA from DePaul University.
• ·Contact: HBTIR@hbtbank.com, (309) 664-4556

25-03-2026

Maze Therapeutics announced positive topline Phase 2 HORIZON data for MZE829 in broad AMKD, with a 35.6% mean uACR reduction at week 12 (61.8% in severe FSGS patients), supporting advancement to a pivotal program, alongside plans for two Phase 2 trials of MZE782 in PKU and CKD in 2026. Cash position strengthened to $360.0M as of Dec 31, 2025 (up from $196.8M in 2024), providing runway into 2028, and Neil Kumar, Ph.D. was appointed to the Board. However, FY2025 net loss widened to $131.1M from a $52.2M profit in 2024, driven by no license revenue (vs. $167.5M in 2024) and increases in R&D expenses (30%) and G&A expenses (31%).

• ·No serious adverse events or severe treatment-related AEs observed in HORIZON trial.
• ·MZE782 Phase 2 POC trials to initiate mid-2026 (PKU) and H2 2026 (CKD).
• ·Conference call held March 25, 2026 at 8:00 am EDT.
• ·Tiered royalties from Shionogi: low double-digits to 20% on net sales.

25-03-2026

Enact Holdings, Inc. reported strong 2025 performance with net income of $674M, record insurance in-force of $273B, new insurance written of $52B, PMIERs sufficiency of 162% ($1.9B excess), and total shareholder return of ~25%, while returning over $500M to shareholders via dividends and repurchases. Operating expenses declined 2% YoY to $218M amid inflation, supporting expense discipline. The 2026 Annual Meeting on May 13 seeks approval for election of 11 directors, advisory vote on NEO compensation, and auditor ratification.

• ·8 of 11 director nominees are independent.
• ·Board diversity: 3/11 female, 3/11 racially/ethnically diverse.
• ·Record date for voting: March 16, 2026.
• ·Virtual annual meeting at www.virtualshareholdermeeting.com/ACT2026.

25-03-2026

Century Communities, Inc. reported strong 2025 financial performance with $4.1B in total revenues, $147.6M net income ($4.86 per diluted share), and a record book value per share of $89.21 (+5% YoY), while delivering 10,792 residential units and returning a record $178.4M to stockholders via dividends and $144M in repurchases despite a challenging environment. Operationally, net new contracts reached 10,326 with a 60,916 lot pipeline, and 94% of deliveries were affordable homes below FHA limits. The proxy seeks approval for director elections, auditor ratification, and say-on-pay, highlighting governance enhancements like reduced executive compensation (e.g., Exec Chairman target STI down 30% from 2024) and board refreshment.

• ·Annual meeting scheduled for May 6, 2026 at 1:00 p.m. MT, Hyatt Regency Denver Tech Center, Denver, CO; record date March 9, 2026.
• ·Net homebuilding debt to net capital ratio: 25.9% as of 2025.
• ·Direct construction costs on starts declined by average $13,000 per home in 2025.
• ·Board governance: 5/7 directors independent (>70%), annual elections, majority vote standard, hedging/pledging prohibitions.
• ·Engaged top stockholders representing 78% of shares in 2025.

25-03-2026

KIORA Pharmaceuticals reported zero revenue in 2025 compared to $16M in 2024, resulting in a net loss of $10.8M versus a $3.6M profit the prior year, driven by the absence of collaboration revenue and higher R&D expenses up 37% to $10.8M. While cash and equivalents rose to $8.7M from $3.8M supported by investing activities, total assets declined to $24.3M from $36.5M and operating cash flow swung to a $10M use from $8.6M provided.

• ·Basic EPS declined to -$2.60 from $0.93 YoY.
• ·In-Process R&D Impairment increased to $4.6M from $2.0M.
• ·Stockholders’ Equity decreased to $16.1M from $25.8M.
• ·Short-Term Investments fell to $8.4M from $23.0M.